| |
| |
| Exchange: |
New York Stock Exchange |
| Security
Type: |
Common |
| Shares
Out: |
5,560,000,000 |
| Market
Cap: |
141.22(B) |
| Last
Volume: |
46,511,071 |
Avg
Vol: |
30,315,820 |
| 52
Week Range: |
$25.26 - $40.28 |
|
| Level
I Sector: |
Health Care |
| Level
II Sector: |
Drugs |
| Level
III Sector: |
Drug Manufacturers - Major |
|
Member Indexes:
|
| |
S&P COMPOSITE 1500 |
|
DOW JONES COMPOSITE |
| |
DOW JONES INDUSTRIAL AVERAGE |
|
NYSE COMPOSITE |
| |
S&P 100 |
|
S&P 500 |
|
Rankings:
|
|
| Insider 3 Months : - |
| Insider 6 Months : 6.5 |
| Insider 3/6 Months : 7.1 |
|
| Guru Rank Number : 710 |
| Guru Rank Value : 1.7 |
| Guru Occurances : 3 |
|
|
|
|
|
| |
|
Company Profile Pfizer is a research-based biopharmaceutical company. Co. is engaged in the discovering, developing, manufacturing, marketing, sales and distribution of biopharmaceutical products. Co.'s business includes: internal medicine, which includes cardiovascular metabolic and pain products; oncology, which includes products in biologics, small molecules, immunotherapies, and biosimilars for cancers; hospital, which includes Co.'s portfolio of sterile injectable and anti-infective medicines, as well as Pfizer CentreOne; vaccines, which includes vaccines brands in pneumococcal disease, meningococcal disease, tick-borne encephalitis and COVID-19; inflammation and immunology; and rare disease.
|
|
|
D/I:
|
|
|
D
is for direct shares.
I is
for indirect shares.
D/I
refers to the Direct or Indirect
shares traded vs. held. |
|
|
|
Forms:
|
|
|
A
Form 4 is a form filed
by an insider to indicate a change
in ownership.
A Form
3 is a form filed by
an insider to indicate an
initial ownership of a security. |
|
|
|
3m +/-:
|
|
|
|
This
represents the company's 3 month
price change. The initial price
is based on the closing price
of the stock on the day the transaction
took place. Purchases & sales
are viewed as long & short
positions respectively.
|
|
|
|
Actions:
|
|
|
| B |
Buy |
| S |
Sell |
| OE |
Option
Exercised |
| A |
Acquired |
| D |
Disposed |
| AB |
Automatic
Buy |
| AS |
Automatic
Sell |
| IO |
Initial
Ownership |
|
|
|
|
Download:
|
|
|
Download only Transactions
Forms. (Default)
Download
only Summary Infomation.
Download
both Transactions and Summary Data
|
|
|
|
|
| |
| |
Summary (Direct Transactions Only)  |
3 Months |
6 Months |
12 Months |
24 Months |
| Total Shares Bought |
0 |
3,000 |
5,000 |
5,000 |
| Total Buy Value |
$0 |
$79,401 |
$156,406 |
$156,406 |
| Total People Bought |
0 |
1 |
1 |
1 |
| Total Buy Transactions |
0 |
1 |
3 |
3 |
| Total Shares Sold |
0 |
0 |
0 |
154,621 |
| Total Sell Value |
$0 |
$0 |
$0 |
$7,584,472 |
| Total People Sold |
0 |
0 |
0 |
5 |
| Total Sell Transactions |
0 |
0 |
0 |
7 |
| End Date |
2024-01-28 |
2023-10-27 |
2023-04-28 |
2022-04-28 |
|
| Filer's Name |
Relation Title |
Off-Dir-10% |
Tran. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
  Lankler Douglas M |
Executive Vice President |
• • – |
2022-02-23 |
4 |
D |
$46.87 |
$4,229,202 |
D/D |
(84,861) |
96,798 |
|
- |
|
| Lankler Douglas M |
Executive Vice President |
• • – |
2022-02-23 |
4 |
OE |
$27.34 |
$3,153,450 |
D/D |
115,342 |
181,659 |
|
- |
|
| Damico Jennifer B. |
SVP & Controller |
• • – |
2022-02-23 |
4 |
D |
$46.87 |
$407,822 |
D/D |
(8,154) |
13,514 |
|
- |
|
| Damico Jennifer B. |
SVP & Controller |
• • – |
2022-02-23 |
4 |
OE |
$27.34 |
$321,190 |
D/D |
11,748 |
21,668 |
|
- |
|
| Fonseca Lidia |
Executive Vice President |
• • – |
2022-01-31 |
4 |
D |
$52.69 |
$351,969 |
D/D |
(6,680) |
34,717 |
|
- |
|
| Mcdermott Michael |
Executive Vice PresidentOffice |
• – – |
2022-01-01 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
66,186 |
|
-11% |
|
| Dolsten Mikael |
President R&D |
• • – |
2021-12-17 |
4 |
OE |
$30.17 |
$2,147,712 |
D/D |
71,187 |
351,637 |
|
- |
|
| Bourla Albert |
Chairman & CEO |
• • – |
2021-12-17 |
4 |
OE |
$25.60 |
$3,289,547 |
D/D |
123,055 |
246,444 |
|
- |
|
| Johnson Rady A |
Executive Vice President |
• • – |
2021-12-03 |
4 |
S |
$53.37 |
$1,015,042 |
D/D |
(19,000) |
55,844 |
|
2% |
|
| Mackenzie Alexander R |
Executive Vice President |
• • – |
2021-12-02 |
4 |
S |
$54.26 |
$2,244,194 |
D/D |
(41,360) |
87,280 |
|
2% |
|
| Susman Sally |
Executive Vice President |
• • – |
2021-11-26 |
4 |
S |
$54.43 |
$2,415,578 |
D/D |
(44,308) |
89,575 |
|
-2% |
|
| Lankler Douglas M |
Executive Vice President |
• • – |
2021-11-26 |
4 |
S |
$54.17 |
$2,174,786 |
D/D |
(40,000) |
66,317 |
|
-2% |
|
| Hwang Angela |
Group President |
• • – |
2021-11-12 |
4 |
S |
$49.59 |
$1,298,002 |
D/D |
(26,170) |
1 |
|
-7% |
|
| Dolsten Mikael |
President R&D |
• • – |
2021-11-11 |
4 |
S |
$50.28 |
$3,000,647 |
D/D |
(59,664) |
279,842 |
|
-5% |
|
| Dolsten Mikael |
President R&D |
• • – |
2021-11-11 |
4 |
OE |
$22.89 |
$5,014,926 |
D/D |
199,548 |
339,506 |
|
- |
|
| Young John D |
Group President |
• • – |
2021-11-11 |
4 |
S |
$50.01 |
$7,508,732 |
D/D |
(150,000) |
312,704 |
|
-5% |
|
| Malik Aamir |
Executive Vice President |
• • – |
2021-08-31 |
4 |
A |
$0.00 |
$0 |
D/D |
43,412 |
43,786 |
|
- |
|
| Damico Jennifer B. |
SVP & Controller |
• • – |
2021-08-13 |
4 |
S |
$48.29 |
$80,226 |
D/D |
(1,661) |
9,769 |
|
-21% |
|
| Damico Jennifer B. |
SVP & Controller |
• • – |
2021-07-30 |
4 |
S |
$42.86 |
$107,150 |
D/D |
(2,500) |
11,430 |
|
-20% |
|
| Blaylock Ronald E |
Director |
• • – |
2021-06-16 |
4 |
GA |
$0.00 |
$0 |
I/I |
4,750 |
4,750 |
|
- |
|
| Blaylock Ronald E |
Director |
• • – |
2021-06-16 |
4 |
GD |
$0.00 |
$0 |
D/D |
4,750 |
8,250 |
|
- |
|
| Young John D |
Group President |
• • – |
2021-05-07 |
4 |
GD |
$0.00 |
$0 |
D/D |
8,830 |
461,761 |
|
- |
|
| Damico Jennifer B. |
SVP & Controller |
• • – |
2021-05-05 |
4 |
S |
$40.82 |
$102,050 |
D/D |
(2,500) |
13,748 |
|
-12% |
|
| Hwang Angela |
Group President |
• • – |
2021-02-27 |
4 |
D |
$33.49 |
$276,468 |
D/D |
(8,040) |
26,171 |
|
- |
|
| Hwang Angela |
Group President |
• • – |
2021-02-27 |
4 |
OE |
$22.35 |
$220,952 |
D/D |
9,886 |
34,211 |
|
- |
|
1390 Records found
|
|
Page 6 of 56 |
|
|
0.14 (0.55%) 
